早产儿散瞳滴眼液尺寸的减小。
Reduction in mydriatic drop size in premature infants.
作者信息
Wheatcroft S, Sharma A, McAllister J
机构信息
Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berkshire.
出版信息
Br J Ophthalmol. 1993 Jun;77(6):364-5. doi: 10.1136/bjo.77.6.364.
Abstract
In a prospective study of 26 premature infants, 5 microliters microdrops were compared with standard 26 microliters eye drops of cyclopentolate 0.5% and phenylephrine 2.5%. There was no statistical difference in pupil dilatation. The 5 microliters microdrops have potentially fewer adverse effects in premature infants.
摘要
在一项针对26名早产儿的前瞻性研究中，将5微升微量滴剂与标准的26微升0.5%环喷托酯和2.5%去氧肾上腺素滴眼液进行了比较。瞳孔散大方面无统计学差异。5微升微量滴剂对早产儿的潜在不良反应可能更少。
相似文献
1
Reduction in mydriatic drop size in premature infants.早产儿散瞳滴眼液尺寸的减小。
Br J Ophthalmol. 1993 Jun;77(6):364-5. doi: 10.1136/bjo.77.6.364.
2
Randomised controlled pilot trial comparing low dose and very low- dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates.随机对照初步试验比较小剂量和极低剂量苯肾上腺素和环戊通微滴给药用于早产儿视网膜病变检查
Arch Dis Child. 2021 Jun;106(6):603-608. doi: 10.1136/archdischild-2019-318733. Epub 2020 Oct 13.
3
Pupil dilatation after single and triple doses of mydriatic agent in preterm infants.早产儿单次及三次使用散瞳剂后的瞳孔扩张情况。
J Med Assoc Thai. 2009 Nov;92(11):1458-62.
4
The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants.环喷托酯、去氧肾上腺素和托吡卡胺的滴入剂量对婴儿瞳孔散大及全身副作用的影响
Acta Ophthalmol Scand. 1997 Apr;75(2):178-80. doi: 10.1111/j.1600-0420.1997.tb00119.x.
5
A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study.一种对早产儿无全身影响的散瞳滴眼液组合：一项前瞻性双盲研究。
J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. doi: 10.3928/0191-3913-19920501-07.
6
A randomized controlled trial to determine the lowest effective dose for adequate mydriasis in premature infants.一项随机对照试验，以确定早产儿充分散瞳的最低有效剂量。
J AAPOS. 2012 Aug;16(4):365-9. doi: 10.1016/j.jaapos.2012.02.017.
7
Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides.环喷托酯与去氧肾上腺素联合用于虹膜色素沉着严重的早产儿散瞳。
J Pediatr Ophthalmol Strabismus. 2000 Jan-Feb;37(1):15-20. doi: 10.3928/0191-3913-20000101-05.
8
Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides.用于筛查深色虹膜早产儿早产儿视网膜病变的散瞳方案比较。
J Pediatr Ophthalmol Strabismus. 2005 May-Jun;42(3):166-73. doi: 10.3928/01913913-20050501-05.
9
Fatal necrotising enterocolitis due to mydriatic eye drops.散瞳眼药水导致的致命性坏死性小肠结肠炎。
J Coll Physicians Surg Pak. 2014 May;24 Suppl 2:S147-9.
10
Efficacy and safety of phenylephrine 2.5% with cyclopentolate 0.5% for retinopathy of prematurity screening in 1246 eye examinations.1246次眼科检查中使用2.5%去氧肾上腺素与0.5%环喷托酯用于早产儿视网膜病变筛查的疗效与安全性。
Eur J Ophthalmol. 2015 May-Jun;25(3):249-53. doi: 10.5301/ejo.5000540. Epub 2014 Nov 14.
引用本文的文献
1
Optimizing instilled drug delivery: a scoping review of microdrops in ophthalmology.优化滴眼剂给药：眼科微滴的范围综述
Graefes Arch Clin Exp Ophthalmol. 2025 Feb 26. doi: 10.1007/s00417-025-06773-1.
2
Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial.用于早产儿视网膜病变筛查的散瞳微滴剂的疗效和安全性：MyMiROPS随机临床试验
JAMA Ophthalmol. 2025 Feb 1;143(2):110-116. doi: 10.1001/jamaophthalmol.2024.5462.
3
Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.用于早产儿视网膜病变筛查的散瞳微滴剂（MyMiROPS）的疗效和安全性：一项非劣效性交叉随机对照试验的研究方案
Trials. 2022 Apr 15;23(1):322. doi: 10.1186/s13063-022-06243-7.
4
Alternative mydriasis techniques for retinopathy of prematurity screening.早产儿视网膜病变筛查的替代散瞳技术。
Int Ophthalmol. 2020 Dec;40(12):3613-3619. doi: 10.1007/s10792-020-01542-x. Epub 2020 Aug 9.
5
Systematic review of mydriatics used for screening of retinopathy in premature infants.用于筛查早产儿视网膜病变的散瞳剂的系统评价
BMJ Paediatr Open. 2019 May 9;3(1):e000448. doi: 10.1136/bmjpo-2019-000448. eCollection 2019.
6
Production and characterization of drug-loaded toroidal vortices from a novel ocular drug delivery device.从新型眼部药物输送装置中制备载药的环形涡旋及其特性研究。
Drug Deliv Transl Res. 2018 Oct;8(5):1139-1151. doi: 10.1007/s13346-018-0553-1.
7
Retinopathy of prematurity screening leading to cardiopulmonary arrest: fatal complication of a benign procedure.早产儿视网膜病变筛查导致心肺骤停：一项良性操作的致命并发症。
BMJ Case Rep. 2016 Jul 28;2016:bcr2016216594. doi: 10.1136/bcr-2016-216594.
8
Neurotoxic Effects of Topical Cyclopentolate.局部用环喷托酯的神经毒性作用。
Med J Armed Forces India. 2010 Jul;66(3):288-9. doi: 10.1016/S0377-1237(10)80069-3. Epub 2011 Jul 21.
9
Severe hypertension and pulmonary edema associated with systemic absorption of topical phenylephrine in a child during retinal surgery.一名儿童在视网膜手术期间因局部应用去氧肾上腺素全身吸收而出现严重高血压和肺水肿。
Saudi J Anaesth. 2012 Jul;6(3):285-8. doi: 10.4103/1658-354X.101224.
10
Lower conjunctival fornix packing for mydriasis in premature infants: a randomized trial.早产儿散瞳的下结膜穹窿填塞：一项随机试验
Clin Ophthalmol. 2012;6:253-6. doi: 10.2147/OPTH.S28714. Epub 2012 Feb 15.
本文引用的文献
1
Systemic effects of mydriatics in low weight infants.
J Pediatr Ophthalmol Strabismus. 1981 Nov-Dec;18(6):42-4. doi: 10.3928/0191-3913-19811101-11.
2
Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants.
Pediatrics. 1981 Aug;68(2):231-4.
3
Pharmacokinetics of topically applied ophthalmic drugs.局部应用眼科药物的药代动力学。
Surv Ophthalmol. 1982 Jan-Feb;26(4):207-18. doi: 10.1016/0039-6257(82)90081-9.
4
Mydriatic and cycloplegic drugs: a review of ocular and systemic complications.
Am J Optom Physiol Opt. 1982 Feb;59(2):162-77.
5
Pupillary responses to mydriatic agents in premature infants.早产儿对散瞳剂的瞳孔反应。
Am J Ophthalmol. 1973 Jun;75(6):988-91. doi: 10.1016/0002-9394(73)91086-6.
6
Systemic cyclopentolate (Cyclogyl) toxicity in the newborn infant.新生儿全身性环喷托酯（Cyclogyl）中毒
J Pediatr. 1973 Mar;82(3):501-5. doi: 10.1016/s0022-3476(73)80134-9.
7
Creating smaller eyedrops by reducing eyedropper tip dimensions.
Am J Ophthalmol. 1985 Apr 15;99(4):460-4. doi: 10.1016/0002-9394(85)90013-3.
8
Feeding intolerance following ophthalmologic examination.
Am J Dis Child. 1985 Apr;139(4):367-8. doi: 10.1001/archpedi.1985.02140060049026.
9
How safe are ocular drugs in pediatrics?儿科眼部药物的安全性如何？
Ophthalmology. 1986 Aug;93(8):1038-40. doi: 10.1016/s0161-6420(86)33624-8.
10
Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption.
Arch Ophthalmol. 1987 Oct;105(10):1364-5. doi: 10.1001/archopht.1987.01060100066027.
Zotero 插件